Dr. Brown on PI3 Kinase Inhibitors in CLL

Jennifer Brown, MD, PhD
Published: Thursday, Mar 02, 2017



Jennifer Brown MD, PhD, director, Chronic Lymphocytic Leukemia Center, senior physician, associate professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses PI3 kinase inhibitors in patients with chronic lymphocytic leukemia (CLL).

There are 2 drugs that inhibit PI3 kinase delta that are in registration trials, Brown explains. The first, duvelisib, also inhibits PI3 kinase gamma, meaning it can target T cells and neutrophils, which has had high activity in CLL.

The other drug, TGR-1202, has had to go through dosing modifications and be reformulated to achieve effective pharmacokinetics in patients. The number of patients on those doses and the duration is relatively limited but they have seen beneficial response rates, Brown states.
 


Jennifer Brown MD, PhD, director, Chronic Lymphocytic Leukemia Center, senior physician, associate professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, discusses PI3 kinase inhibitors in patients with chronic lymphocytic leukemia (CLL).

There are 2 drugs that inhibit PI3 kinase delta that are in registration trials, Brown explains. The first, duvelisib, also inhibits PI3 kinase gamma, meaning it can target T cells and neutrophils, which has had high activity in CLL.

The other drug, TGR-1202, has had to go through dosing modifications and be reformulated to achieve effective pharmacokinetics in patients. The number of patients on those doses and the duration is relatively limited but they have seen beneficial response rates, Brown states.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Oncology Briefings™: Overcoming Chronic Iron Overload in Pediatric AML and MDSJun 30, 20181.0
Publication Bottom Border
Border Publication
x